San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Symposium Set to Offer Businesses Some Health Care Solutions June 19

Intercare Insurance Solutions, a HUB International Co., is holding a Corporate Wellness Symposium June 19.

So Long and Thanks for All the Health Care, Biotechnology News

(Editor’s note: This is the final column on biotechnology and health care from Meghana Keshavan, who leaves the San Diego Business Journal as of this issue to join a national online publication focused on innovation in the health care industry.)

Pfenex Seeking $74.8M in Initial Public Offering

Biotech: Company Sees Huge Market for Biosimilars As Patents on Biologics End

Pfenex Inc., a spinoff of Dow Chemical Co., is the latest San Diego biotech to file for an initial public offering. The company is looking to raise $74.8 million as it focuses development on a growing class of drugs called biosimilars, which are projected to make a large dent in big pharma sales as patents for biologic drugs expire.

Tease photo

Orexigen Stock Slides After Delay of FDA Approval for Weight-Loss Drug

Possible approval of weight-loss drug pushed back to September.

Tease photo

Oceanside Building Housing Surgery Center Sells for $4.8 Million

The property was fully leased.

Nominations Are Open for San Diego’s Healthcare Champions Awards

The San Diego Business Journal is now accepting nominations for 2014 Healthcare Champions awards, which honors individuals within the San Diego community who have demonstrated exceptional leadership and innovation in the health care industry.

Tease photo

Site of Now-Closed Burns Drugs Bought for $5.3 Million

Former home of La Jolla drug store was bought.

Tease photo

Isis Pharmaceuticals Gets Multimillion-Dollar Milestone Payment

Isis Pharmaceuticals Inc. has received a large milestone payment from AstraZeneca PLC.

Solstice Biologics Names CEO With Boston VC Pedigree

Venture capital veteran from Boston joining San Diego biotech as CEO.

Pfenex Inc. Aims for $74.8M IPO

Pfenex Inc., a spinoff of Dow Chemical Co., is the latest San Diego biotech to file for an initial public offering, looking to raise $74.8 million to fund its development of biosimilars.

New President, CFO at Celladon Says Co. Ripe to Expand Staff

I chatted recently with Paul Cleveland, a veteran biotech finance guy who has recently been brought on as president and chief financial officer for the newly public gene therapy company Celladon Corp. Cleveland most recently was CFO of Aragon Pharmaceuticals Inc., a San Diego drugmaker sold to Johnson & Johnson last August for $1 billion.

Tease photo

Pathway Launches Breast Cancer Test With Philanthropic Twist

biotech: Supreme Court Ruling on Gene Patent Case Clears Path to Competition

San Diego’s Pathway Genomics Corp. is employing a social entrepreneurship model as it launches its new genetic test for breast cancer — entering a market made more high profile and competitive after a U.S. Supreme Court ruling last year that invalidated patents on genes.

Covert Stepping Down as CEO of Palomar Health

Michael Covert is stepping down after more than a decade as CEO of Palomar Health, heading to Texas in August to run six Houston-area hospitals.

Tease photo

Healthy Appetite

HEALTH: Cos. Seek to Tap Into Consumers’ Desire to Take Control of Their Health

Ayub Khattak’s big idea started with the swine flu.

J. Craig Venter Institute to Receive $25M for Studies of Pathogen Genomics

The National Institutes of Health has awarded up to $25 million to the La Jolla-based J. Craig Venter Institute to study the genetics of infectious diseases like malaria and influenza.